Search

Shobha Kantamneni

Examiner (ID: 15371, Phone: (571)272-2930 , Office: P/1627 )

Most Active Art Unit
1627
Art Unit(s)
1627, 1623, 1617
Total Applications
1212
Issued Applications
306
Pending Applications
120
Abandoned Applications
793

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17336147 [patent_doc_number] => 20220002478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES [patent_app_type] => utility [patent_app_number] => 17/475914 [patent_app_country] => US [patent_app_date] => 2021-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20695 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17475914 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/475914
Polymeric biomaterials derived from phenolic monomers and their medical uses Sep 14, 2021 Issued
Array ( [id] => 17392412 [patent_doc_number] => 11241400 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-02-08 [patent_title] => Compositions comprising ephedrine or an ephedrine salt and methods of making and using same [patent_app_type] => utility [patent_app_number] => 17/465697 [patent_app_country] => US [patent_app_date] => 2021-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18960 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465697 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/465697
Compositions comprising ephedrine or an ephedrine salt and methods of making and using same Sep 1, 2021 Issued
Array ( [id] => 17426777 [patent_doc_number] => 20220054485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => METHODS OF TREATING RIGHT VENTRICULAR FUNCTION IN PULMONARY HYPERTENSION [patent_app_type] => utility [patent_app_number] => 17/406836 [patent_app_country] => US [patent_app_date] => 2021-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18180 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17406836 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/406836
METHODS OF TREATING RIGHT VENTRICULAR FUNCTION IN PULMONARY HYPERTENSION Aug 18, 2021 Pending
Array ( [id] => 19960294 [patent_doc_number] => 12329766 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-06-17 [patent_title] => Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development [patent_app_type] => utility [patent_app_number] => 17/445449 [patent_app_country] => US [patent_app_date] => 2021-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57164 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 285 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17445449 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/445449
Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development Aug 18, 2021 Issued
Array ( [id] => 19209619 [patent_doc_number] => 11998657 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-04 [patent_title] => Biodegradable, thermally responsive injectable hydrogel for treatment of ischemic cardiomyopathy [patent_app_type] => utility [patent_app_number] => 17/394984 [patent_app_country] => US [patent_app_date] => 2021-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 18489 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17394984 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/394984
Biodegradable, thermally responsive injectable hydrogel for treatment of ischemic cardiomyopathy Aug 4, 2021 Issued
Array ( [id] => 17227005 [patent_doc_number] => 20210353561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => COMPOSITIONS COMPRISING EPHEDRINE OR AN EPHEDRINE SALT AND METHODS OF MAKING AND USING SAME [patent_app_type] => utility [patent_app_number] => 17/381770 [patent_app_country] => US [patent_app_date] => 2021-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18958 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17381770 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/381770
Compositions comprising ephedrine or an ephedrine salt and methods of making and using same Jul 20, 2021 Issued
Array ( [id] => 19439981 [patent_doc_number] => 12090207 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-17 [patent_title] => Drug delivery composition, method forming the same and method for treating inner ear disorders [patent_app_type] => utility [patent_app_number] => 17/379986 [patent_app_country] => US [patent_app_date] => 2021-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 20 [patent_no_of_words] => 8045 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17379986 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/379986
Drug delivery composition, method forming the same and method for treating inner ear disorders Jul 18, 2021 Issued
Array ( [id] => 17297705 [patent_doc_number] => 20210393544 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => TRANSDERMAL DRUG DELIVERY SYSTEM FOR KETAMINE [patent_app_type] => utility [patent_app_number] => 17/352006 [patent_app_country] => US [patent_app_date] => 2021-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43515 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17352006 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/352006
Transdermal drug delivery system for ketamine Jun 17, 2021 Issued
Array ( [id] => 18018976 [patent_doc_number] => 20220370475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => Methods of Treating Hypogonadism with Transnasal Testosterone Bio-Adhesive Gel Formulations in Male With Allergic Rhinitis, And Methods for Preventing An Allergic Rhinitis Event [patent_app_type] => utility [patent_app_number] => 17/351003 [patent_app_country] => US [patent_app_date] => 2021-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67626 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17351003 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/351003
Methods of Treating Hypogonadism with Transnasal Testosterone Bio-Adhesive Gel Formulations in Male With Allergic Rhinitis, And Methods for Preventing An Allergic Rhinitis Event Jun 16, 2021 Abandoned
Array ( [id] => 17274320 [patent_doc_number] => 20210380518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-09 [patent_title] => COMPOUNDS AND METHODS OF USING COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASES [patent_app_type] => utility [patent_app_number] => 17/342148 [patent_app_country] => US [patent_app_date] => 2021-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9304 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17342148 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/342148
COMPOUNDS AND METHODS OF USING COMPOUNDS FOR TREATMENT OF RESPIRATORY DISEASES Jun 7, 2021 Abandoned
Array ( [id] => 17110009 [patent_doc_number] => 20210290606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-23 [patent_title] => METHOD TO PREVENT AND TREAT OSTEOARTHRITIS BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS [patent_app_type] => utility [patent_app_number] => 17/339569 [patent_app_country] => US [patent_app_date] => 2021-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15390 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17339569 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/339569
METHOD TO PREVENT AND TREAT OSTEOARTHRITIS BY CALCIUM CHANNEL BLOCKERS, ANGIOTENSIN CONVERTING ENZYME INHIBITORS, AND ANGIOTENSIN RECEPTOR BLOCKERS Jun 3, 2021 Abandoned
Array ( [id] => 19353116 [patent_doc_number] => 12053541 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-08-06 [patent_title] => Compositions for reducing hair loss and/or increasing hair regrowth [patent_app_type] => utility [patent_app_number] => 17/336283 [patent_app_country] => US [patent_app_date] => 2021-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 115 [patent_figures_cnt] => 115 [patent_no_of_words] => 3629 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17336283 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/336283
Compositions for reducing hair loss and/or increasing hair regrowth May 31, 2021 Issued
Array ( [id] => 18420003 [patent_doc_number] => 20230174464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => MYRISTOYL DERIVATIVES OF 9-AMINO-DOXYCYCLINE FOR TARGETING CANCER STEM CELLS AND PREVENTING METASTASIS [patent_app_type] => utility [patent_app_number] => 17/924614 [patent_app_country] => US [patent_app_date] => 2021-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9337 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17924614 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/924614
MYRISTOYL DERIVATIVES OF 9-AMINO-DOXYCYCLINE FOR TARGETING CANCER STEM CELLS AND PREVENTING METASTASIS May 12, 2021 Pending
Array ( [id] => 17385543 [patent_doc_number] => 20220033395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => INDOLIN-2-ONE OR PYRROLO -PYRIDIN -2 -ONE DERIVATIVES [patent_app_type] => utility [patent_app_number] => 17/238013 [patent_app_country] => US [patent_app_date] => 2021-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17199 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17238013 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/238013
INDOLIN-2-ONE OR PYRROLO -PYRIDIN -2 -ONE DERIVATIVES Apr 21, 2021 Abandoned
Array ( [id] => 19058910 [patent_doc_number] => 11938102 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-26 [patent_title] => S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis [patent_app_type] => utility [patent_app_number] => 17/231789 [patent_app_country] => US [patent_app_date] => 2021-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 37 [patent_no_of_words] => 21757 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231789 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/231789
S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis Apr 14, 2021 Issued
Array ( [id] => 19425057 [patent_doc_number] => 12084459 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-09-10 [patent_title] => 2-(4-{1-[6-(4-isopropyl-phenyl)-imidazo[2,1-b][1,3,4]thiadiazol-2-yl]-piperidin-4-ylmethyl}-piperazin-1-yl)-ethanol and use thereof [patent_app_type] => utility [patent_app_number] => 17/212845 [patent_app_country] => US [patent_app_date] => 2021-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 2293 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17212845 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/212845
2-(4-{1-[6-(4-isopropyl-phenyl)-imidazo[2,1-b][1,3,4]thiadiazol-2-yl]-piperidin-4-ylmethyl}-piperazin-1-yl)-ethanol and use thereof Mar 24, 2021 Issued
Array ( [id] => 17412603 [patent_doc_number] => 20220047507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => MELFLUFEN DOSAGE REGIMENS FOR CANCER [patent_app_type] => utility [patent_app_number] => 17/210699 [patent_app_country] => US [patent_app_date] => 2021-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20963 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210699 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/210699
MELFLUFEN DOSAGE REGIMENS FOR CANCER Mar 23, 2021 Abandoned
Array ( [id] => 19081924 [patent_doc_number] => 20240108725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-04 [patent_title] => METHOD FOR TREATING CANCER AND SYSTEM FOR SAME [patent_app_type] => utility [patent_app_number] => 17/768769 [patent_app_country] => US [patent_app_date] => 2021-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13126 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17768769 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/768769
METHOD FOR TREATING CANCER AND SYSTEM FOR SAME Mar 23, 2021 Pending
Array ( [id] => 17080673 [patent_doc_number] => 20210275679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => HEPAROSAN POLYMERS AND METHODS OF MAKING AND USING SAME FOR THE ENHANCEMENT OF THERPEUTICS [patent_app_type] => utility [patent_app_number] => 17/199270 [patent_app_country] => US [patent_app_date] => 2021-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15134 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199270 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/199270
HEPAROSAN POLYMERS AND METHODS OF MAKING AND USING SAME FOR THE ENHANCEMENT OF THERPEUTICS Mar 10, 2021 Abandoned
Array ( [id] => 16900697 [patent_doc_number] => 20210179613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => GHRELIN RECEPTOR AGONIST FOR TREATMENT OF CACHEXIA [patent_app_type] => utility [patent_app_number] => 17/189552 [patent_app_country] => US [patent_app_date] => 2021-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13386 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17189552 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/189552
GHRELIN RECEPTOR AGONIST FOR TREATMENT OF CACHEXIA Mar 1, 2021 Abandoned
Menu